Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial

BACKGROUND: Vaccination of human immunodeficiency virus (HIV)-infected infants with bacille Calmette-Guérin (BCG) is contraindicated. HIV-exposed newborns need a new tuberculosis vaccination strategy that protects against tuberculosis early in life and avoids the potential risk of BCG disease until...

Descripción completa

Detalles Bibliográficos
Autores principales: Nemes, Elisa, Hesseling, Anneke C, Tameris, Michele, Mauff, Katya, Downing, Katrina, Mulenga, Humphrey, Rose, Penelope, van der Zalm, Marieke, Mbaba, Sharon, Van As, Danelle, Hanekom, Willem A, Walzl, Gerhard, Scriba, Thomas J, McShane, Helen, Hatherill, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849090/
https://www.ncbi.nlm.nih.gov/pubmed/29028973
http://dx.doi.org/10.1093/cid/cix834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849090/
https://www.ncbi.nlm.nih.gov/pubmed/29028973
http://dx.doi.org/10.1093/cid/cix834

Ejemplares similares